Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic polymorphisms and prostate cancer risk.

Andrea Gsur1, Elisabeth Feik, Stephan Madersbacher

  • 1Division of Applied and Experimental Oncology, Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. andrea.gsur@univie.ac.at

World Journal of Urology
|December 3, 2003
PubMed
Summary

Identifying genetic polymorphisms can help assess prostate cancer (PC) risk early. This allows for timely chemopreventive interventions, improving treatment effectiveness for PC susceptibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A deep learning framework for efficient pathology image analysis.

Nature communications·2026
Same author

Spatial biomarker discovery via interpretable semantic learning in histopathology.

Cancer cell·2026
Same author

Bridging urology and palliative care: a narrative review of current practice and evolving priorities.

Current opinion in urology·2026
Same author

Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes.

BMC cancer·2025
Same author

Sexual function and its association with psychosocial factors after penile inversion vulvo-vaginoplasty without scrotal skin grafts: a retrospective study using the oMtFSFI.

BMC urology·2025
Same author

Multiple polygenic score approach in colorectal cancer risk prediction.

Scientific reports·2025

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Prostate cancer (PC) susceptibility is influenced by genetic factors.
  • Early risk assessment is crucial for effective intervention.
  • Genetic polymorphisms offer potential biomarkers for PC risk.

Purpose of the Study:

  • To review genetic polymorphisms associated with prostate cancer (PC) risk.
  • To identify genes involved in the etiology of PC.
  • To explore the role of these genes in early risk assessment and chemoprevention.

Main Methods:

  • Review of published case-control studies.
  • Meta-analyses of polymorphic genes.
  • Focus on specific genes: androgen receptor (AR), prostate-specific antigen (PSA), SRD5A2, CYP17, CYP3A4, and ELAC2.

Related Experiment Videos

Main Results:

  • Common genetic polymorphisms are linked to PC susceptibility.
  • Specific genes like AR, SRD5A2, CYP17, and ELAC2 show potential associations with PC etiology.
  • These findings support the use of genetic markers for risk stratification.

Conclusions:

  • Identification of genetic polymorphisms can enable early PC risk assessment.
  • Earlier risk assessment facilitates timely and potentially more effective chemopreventive strategies.
  • Further research into these genetic factors can refine PC prevention and management.